Organization consolidation and presentation of financial statements.

No definition available.

Name:	ibrx_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems
Namespace Prefix:	ibrx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Ownership percentage acquired on fully diluted bases upon consummation of merger.

+ References

No definition available.

+ Details

Name:	ibrx_OwnershipPercentageAcquiredOnFullyDilutedBasesUponConsummationOfMerger
Namespace Prefix:	ibrx_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Ownership percentage by key executives.

+ References

No definition available.

+ Details

Name:	ibrx_OwnershipPercentageByKeyExecutives
Namespace Prefix:	ibrx_
Data Type:	dtr-types1:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

The amount of cash paid during the reporting period for charges associated with the mergers.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForMergerRelatedCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=ibrx_ExecutiveChairmanAndGlobalChiefScientificAndMedicalOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=ibrx_NantKwestMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=ibrx_NantCellInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Description of Business - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Mar. 09, 2021	Dec. 31, 2021	Dec. 31, 2023	Dec. 31, 2022
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001		$ 0.0001	$ 0.0001
Selling General and Administrative Expense
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Merger-related costs		$ 13.0
Executive Chairman and Global Chief Scientific and Medical Officer
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Ownership percentage of outstanding shares of company	81.80%
NantKwest
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Ownership percentage held by stockholders upon consummation of merger	28.50%
NantCell
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Common stock, par value (in dollars per share)	$ 0.001
Ownership percentage held by stockholders upon consummation of merger	71.50%